Plus: Novo Nordisk secures injunction over Ozempic, Wegovy claims.

September 16, 2026

1. Can an AI-generated drug slow aging? 6 notes Full story

2. Mayo Clinic, Thermo Fisher debut disease detection joint venture Full story

3. Reimbursement complexity threatens pharmacy margins. See how leading health systems protect them in this webinar.

 

4. Lung disease drug posts record 56.3% reduction in trial: 5 notes Full story

5. Wegovy cuts obesity rate in young children: Study Full story

6. Pushing cancer research forward without federal backing is the question every academic cancer center is asking, and the leaders answering it are at Becker’s Fall Oncology Executive Summit Nov 4-5 in Chicago. Apply to attend as a reviewer here.

 

7. 100% of cancer centers surveyed have 1 drug in shortage: 6 notes Full story

8. Novo Nordisk secures injunction over Ozempic, Wegovy claims Full story

Becker’s Learning Opportunities

9. Mary Washington’s CEO on freeing beds by fixing what patients never see here.

10. Faster respiratory answers can shorten stays and curb antibiotic use. Get the short guide here.

11. Healthcare ERP cannot be separated from the EHR. What that means for readiness: here.

12. Becker’s September webinar lineup: hospital AI, nonopioid pain care and analytics governance. See the sessions here.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication